PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2019-09-16

Date Title Company
16-Sep-2019 AMPAC Fine Chemicals and SK biotek Become New US Corporation Focused on Expanded Support to the World's Pharmaceutical Industry SK pharmteco
16-Sep-2019 Kas Subramanian, PhD Joins Applied BioMath, LLC as Senior Director of Preclinical Modeling Applied BioMath, LLC
16-Sep-2019 Business growth fuels office relocation for Envision Pharma Group Envision Pharma Group
16-Sep-2019 CROMSOURCE Consolidates its Hybrid Services Model CROMSOURCE
16-Sep-2019 World Alzheimer’s Day a timely reminder of the urgent need for disease-modifying drugs to tackle slow development, says GlobalData GlobalData
16-Sep-2019 Corp Comms ERT
16-Sep-2019 ABPI comment on Operation Yellowhammer publication ABPI
16-Sep-2019 Proceeds to fund multi-centre study of STAR Mapping to improve outcomes of persistent Atrial Fibrillation treatment RHYTHM AI Ltd
16-Sep-2019 AGM Trading Update ReNeuron Group plc
16-Sep-2019 International survey reveals shared burden of hypoglycaemia for people living with diabetes and their families Novo Nordisk Ltd
16-Sep-2019 ABSTRACT ON ASLAN PHARMACEUTICALS’ VARLITINIB ACCEPTED FOR POSTER PRESENTATION AT ESMO ASIA CONGRESS 2019 ASLAN Pharmaceuticals
16-Sep-2019 Merieux NutriSciences Receives Non-GMO Project Approval Merieux NutriSciences
16-Sep-2019 EXPERTS CALL FOR MORE RESEARCH INTO CHILDHOOD CANCER TREATMENTS TO COMBAT LATE EFFECTS J+D Forecasting
16-Sep-2019 Nanoform strengthens board with appointment of Mads Laustsen Nanoform
16-Sep-2019 ValiRx announces that in addition to pharmacokinetic and toxicology data, clinical trial results show VAL201 behaves as predicted in reducing prostate cancer progression ValiRx plc
16-Sep-2019 Destiny Pharma awarded grant to fund a research collaboration with the University of Sheffield targeting ophthalmic bacterial and fungal infections Destiny Pharma plc
16-Sep-2019 Proposed Special Dividend and Share Consolidation, Share Buyback Programme and Dividend Reinvestment Plan Vectura Group plc
16-Sep-2019 RHYTHM AI Successfully Closes Seed Financing Round RHYTHM AI Ltd
16-Sep-2019 Novartis formally announces TALON, a global clinical trial in wet AMD comparing brolucizumab vs aflibercept in two primary endpoints Novartis Pharmaceuticals
16-Sep-2019 IRBM signs agreement with MD Anderson Cancer Center to generate novel immune-checkpoint monoclonal antibodies. IRBM